Naar www.iknl.nl
- Algemeen > Pijn bij gevorderde stadia van COPD of H
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Laatst gewijzigd: 2019-12-06, Versie: 1.0, Verantwoording: Nederlandse Vereniging voor Anesthesiologie, Type: Landelijke richtlijn

Referentielijst

1 - Ahmedzai S (1997)
Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. J Pain Symptom Manage 1997;13:254-61. [link]
 
2 - Ahmedzai SH (2010)
Ahmedzai SH, Boland J. Constipation in people prescribed opioids. BMJ Clin Evid. 2010; 2010. pii: 2407. [link]
 
3 - Alemzadeh-Ansari MJ (2017)
Alemzadeh-Ansari MJ, Ansari-Ramandi MM, Naderi N. Chronic pain in chronic heart failure: a review article. J Tehran Heart Cent 2017; 12(2): 49-56. [link]
 
4 - Beernaert K (2013)
Beernaert K, Cohen J, Deliens L, et al. Referral to palliative care in COPD and other chronic diseases: a population-based study. Respir Med 2013;107(11):1731-9. [link]
 
5 - Bhattarai P (2016)
Bhattarai P, Hickman L, Phillips JL. Pain among hospitalized older people with heart failure and their preparation to manage this symptom on discharge: a descriptive-observational study. Contemp Nurse 2016; 52: 204-215. [link]
 
6 - Borge CR (2011)
Borge CR, Wahl AK, Moum T. Pain and quality of life with chronic obstructive pulmonary disease. Heart & Lung 2011; 40: E90-E101. [link]
 
7 - Chen YW (2017)
Chen YW, Camp PG, Coxson HO, et al. Comorbidities that cause pain and the contributors to pain in individuals with chronic obstructive pulmonary disease. Arch Phys Med Rehab 2017; 98: 1535-1543. [link]
 
8 - Cherny N (2001)
Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001;19:2542-54. [link]
 
9 - Chey WD (2014)
Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain.N Engl J Med. 2014; 370: 2387-2396. [link]
 
10 - Clark AJ (2004)
Clark AJ, Ahmedzai SH, Allan LG, et al. Efficacy and safety of transdermal fentanyl and sustained-release oralmorphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin 2004;20:1419-28. [link]
 
11 - Dale O (2010)
Dale O, Moksnes K, Kaasa S. European Palliatieve Care Research collaborative pain guidelines. Opioid switching to improve analgesia or seduce side effcts. A systematic review. Palliat Med 2010; 25: 494-503. [link]
 
12 - Dam van Isselt van EF (2014)
Dam van Isselt van EF, Groenewegen-Sipkema KH, Spruit-van Eijk M, Chavannes NH, de Waal MW, Janssen DJ, Achterberg WP. Pain in patients with COPD: a systematic review and meta-analysis. BMJ Open 2014; 4(9): e005898. [link]
 
13 - Davies A (2011)
Davies A, Zeppetella G, Andersen S, et al. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011; 13: 756-763 [link]
 
14 - Davies AN (2009)
Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009; 13(4): 331-8. [link]
 
15 - Eizenga WH (2006)
Eizenga WH, De Bont M, Vriezen JA, et al. METC. Landelijke eerstelijns samenwerkingsafspraak palliatieve zorg. Huisarts en Wetenschap 2006; 49: 308-312. [link]
 
16 - Els C (2017)
Els C, Jackson TD. Kuny D, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Syst Rev 2017; 10: CD012509. [link]
 
17 - Evangelista LS (2009)
Evangelista LS, Sackett E, Dracup K. Pain and heart failure: unrecognized and untreated. Eur J Carciovasc Nursing 2009; 8: 169-173. [link]
 
18 - Finnerup NB (2016)
Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain 2016; 157:1599-1606. [link]
 
19 - Gardiner C (2010)
Gardiner C, Gott M, Payne S, et al. Exploring the care needs of patients with advanced COPD: an overview of the literature. Respir Med 2010;104(2):159-65. [link]
 
20 - Godfrey C (2006)
Godfrey C, Harrison MB, Medves J, Tranmer JE. The symptom of pain with heart failure: a systematic review. J Card Fail 2006; 12(4): 307-13. [link]
 
21 - Goodlin SJ (2012)
Goodlin SJ, Wingate S, Albert NM, et L. Investigating pain in heart failure patients: the pain assessment, incidence, and nature in heart failure (PAIN-HF) Study.J Cardiac Faiure 2012; 18: 776-783. [link]
 
22 - Gore JM (2000)
Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000;55(12):1000-6. [link]
 
23 - Graeff A de (2006)
Graeff A de, Krol RJA. Richtlijn obstipatie. In: Graeff A de, Hesselmann GM, Krol RJA, et al. Richtlijnen voor de praktijk. Utrecht: Vereniging voor Integrale Kankercentra, 2006;b:521-36. [link]
 
24 - HajGhanbari B (2014)
HajGhanbari B, Yamabayashi C, Garland SJ, Road JD, Reid WD. The relationship between pain and comorbid health conditions in people with chronic obstructive pulmonary disease. Cardiopulm Phys Ther J 2014; 25: 29-35.
 
25 - IASP (1994)
IASP. Task force on taxonomy. Classification of chronic pain. Seattle: IASP Press, 1994
 
26 - IKNL/Palliactief (2017)
IKNL/Palliactief 2017, Kwaliteitskader palliatieve zorg Nederland, 2017. [link]
 
27 - Janssen DJ (2008)
Janssen DJ, Spruit MA, Wouters EF, Schols JM. Daily symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med 2008; 22,938-948. [link]
 
28 - Joshi M (2012)
Joshi M, Joshi A, Bartter T. Symptom burden in chronic obstructive pulmonary disease and cancer. Curr Opin Pulm Med 2012;18(2):97-103. [link]
 
29 - KNMP Kennisbank (2019)
KNMP Kennisbank 2019. [link]
 
30 - Laugsand EA (2011)
Laugsand EA, Kaasa S, Klepstad P. Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat Med. 2011;25(5):442-53. [link]
 
31 - Lee A L (2015)
Lee A L, Harrison SL, Goldstein RS, Brooks D. Pain and its clinical associations in individuals with COPD: a systematic review. Chest 2015; 147: 1246-1258. [link]
 
32 - Lee M (2011)
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14(2): 145-61. [link]
 
33 - Light-McGroary KA (2013)
Light-McGroary KA, Goodlin SJ. The challenges of understanding and managing pain in the heart failure patiŽnt. Curr Opinion 2013; 7: 14-20. [link]
 
34 - Loeser JD (1999)
Loeser JD, Melzack R. Pain: an overview. The Lancet 1999: 1607-1609. [link]
 
35 - Loeser JD (1989)
Loeser JD, In Seitz FC, JCarr JE, Covey M (Eds.): Issues in behavioral medicine. Bozema, MT: Clinical Management Consultants, 1989, pp. 16-20.
 
36 - Lopez-Saca JM (2013)
Lopez-Saca JM, Lopez Guzman J, Centena C. A systematic review of the influence of opioids on advanced cancer patient survival. Curr opinion 2013; 7 ; 424-439. [link]
 
37 - McCaffery M (1968)

McCaffery, M. Nursing practice theories related to cognition, bodily pain, and man-environment interactions. University of California at Los Angeles Students’ Store, Los Angeles; 1968.

 
38 - McNicol E (2003)
McNicol E, Horowicz-Mehler N, Fisk R, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-56. [link]
 
39 - McNicol E (2008)
McNicol E. Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. J Pain Palliat Care Pharmacotherapy. 2008; 22(4): 270-81. [link]
 
40 - Mehta N (2016)
Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review. Postgrad Med. 2016;128(3): 282-9. [link]
 
41 - Mercadante S (2001)
Mercadante S, Casuccio A, Fulfaro F, et al. Switching from morphine to methadone to improve analgesia and toler-ability in cancer patients. A prospective study. J Clin Oncol 2001;19:2898-904. [link]
 
42 - Moore S (2002)
Moore S, Corner J, Haviland J, et al. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ 2002; 325: 1-7. [link]
 
43 - Nolte K (2015)
Nolte K, Herrmann-Lingen C, Wachter R, et al. Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol 2015; 22: 582-93. [link]
 
44 - Oldenmenger WH (2006)
Oldenmenger WH, Stronks DL, Terwiel CTM, et al. Naar een landelijke, uniforme verpleegkundige Pijnanamnese. Psychometrische kwaliteiten. Nederlands Tijdschrift voor Pijnbestrijding 2006, nr 2: 2-6. [link]
 
45 - Piotrowicz E (2015)
Piotrowicz E, Stepnowska M, Leszczynska-Iwanicka K, et al. Quality of life in heart failure patiŽnts undergoing home-based telerehabilitation versus outpatient rehabilitation, a randomized controlled study. Eur J Cardiovasc Nursing 2015; 14: 256-63.† [link]
 
46 - Ruston T (2013)
Ruston T, Hunter K, Cummings G, Lazarescu L. Efficacy and side-effect profiles of lactulose, docusate sodium and sennosides compared to PEG in opioid-induced constipation: a systematic review. Can Oncol Nurs J. 2013; 23(4): 236-46. [link]
 
47 - Sande TA (2019)
Sande TA, Laird BJA, Fallon MT. The management of opioid-induced nausea and vomiting in patients with cancer: a systematic review. J Palliat Med 2019; 22: 9097. [link]
 
48 - Saunders C (1984)
Saunders C. The philosophy of terminal care. In: Sunders C (ed). The management of terminal malignant illness. Baltimore MD: Arnold Publishers, 1984, pp 232-241.
 
49 - Sivanesan E (2016)
Sivanesan E, Gitlin MC, Candiotti KA. Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment. Anesthesia and analgesia. 2016;123(4):836-43. [link]
 
50 - Stone P (2011)
Stone P. Minton O. European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? Palliat Med 2011; 25: 431-441. [link]
 
51 - Verberkt CA (2017)
Verberkt CA, van den Beuken-van Everdingen MHJ, Schols JMGA, et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur Resp J 2017; 52: pii: 1800882. doi: 10.1183/13993003.00882-2018. [link]
 
52 - Volkow ND (2016)
Volkow ND, Mclellan AT. Opioid abuse in chronic pain - misconceptions and mitigation. N Engl J Med 2016; 374: 1253-1263. [link]
 
53 - Davies AN (2009)

Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G. The management of cancer-related breakthrough pain: Recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009; 13(4): 331-8. # https://www.ncbi.nlm.nih.gov/pubmed/18707904

 

 
54 - IASP (2008)

IASP. Total cancer pain, 2008.

 
55 - Chang VT (2006)

Chang VT, Janjan N, Jain S, et al. Update in cancer pain syndromes. J Palliat Med 2006; 9: 1414-1434. # https://www.ncbi.nlm.nih.gov/pubmed/17187550